Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as its CEO from 1 April 2025.
The company’s board of directors followed the nomination committee’s report, appointing Okuzawa to ensure the achievement of the year’s goals and strengthen its management structure.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,